在平台试验中治疗效果的适应性和异质性 - - 两个方法研究的协议
Tine Sylvest Meyhoff1, Aksel Karl Georg Jensen1,2, Anders Perner1,3
1Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Acta anaesthesiologica Scandinavica
|May 7, 2025
概括
适应性平台试验可以改善医疗保健,但是复杂的. 本研究的特点是治疗效果评估的异质性以及这些试验中的适应性,以指导未来的设计.
科学领域:
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
- 药学研究 药学研究
背景情况:
- 适应性平台试验为医学进步提供了先进的基础设施,但也带来了方法方面的挑战.
- 评估治疗效应 (HTE) 的异质性和适应性策略,就像停止规则一样,是关键但复杂的特征.
- 了解这些复杂性对于优化自适应平台试验设计至关重要.
研究的目的:
- 描述在适应性平台试验中对治疗效应 (HTE) 不同质性的评估.
- 在这些试验中描述适应的使用和方法特征,包括适应性停止规则.
- 为改进自适应平台试验设计提供方法学特征的概述.
主要方法:
- 基于系统的文献搜索和数据提取的两项方法研究.
- 包括从2005年起进行的自适应平台试验.
- 独立的,重复的查和数据提取;研究I关注HTE评估方法,研究II关注适应和停止规则.
主要成果:
- (研究I) 评估各种方法来评估治疗效应 (HTE) 的异质性.
- (研究II) 在适应性平台试验中使用的各种适应和停止规则的表征.
- 确定HTE评估和试验调整的关键方法特征.
结论:
- 这些研究概述了适应性平台试验中关于HTE和适应性的关键方法方面的概述.
- 加强对评估方法的了解可以改善自适应平台试验的设计.
- 确定了适应性平台试验中未来方法开发的领域.
相关概念视频
Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K
Clinical Trials: Overview
2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
Randomized Experiments
6.6K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.6K
Blinding
2.3K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.3K


